Overcoming erlotinib resistance with STAT3 inhibition in pancreatic cancer

被引：2
|
作者：
Salzberg, Matthew Philip
Merchant, Nipun B.
机构：
[1] Univ Miami, Jackson Mem Hosp, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Med Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：1
相关论文
共 50 条
  • [21] STAT3 Mediates Regulation of the Tumor Microenvironment in Pancreatic Cancer
    Nagathihalli, N. S.
    Beesetty, Y.
    Reyzer, M.
    Shi, C.
    Caprioli, R.
    Merchant, N. B.
    [J]. PANCREAS, 2011, 40 (08) : 1342 - 1342
  • [22] Involvement of STAT3 Signaling in Proliferation of Pancreatic Cancer Cells
    Park, M.
    Lim, J. W.
    Kim, H.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (08) : 1660 - 1660
  • [23] Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
    Li, Rui
    Hu, Zhongliang
    Sun, Shi-Yong
    Chen, Zhuo G.
    Owonikoko, Taofeek K.
    Sica, Gabriel L.
    Ramalingam, Suresh S.
    Curran, Walter J.
    Khuri, Fadlo R.
    Deng, Xingming
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) : 2200 - 2212
  • [24] Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
    Huang, Shuling
    Chen, Min
    Shen, Yonghua
    Shen, Weidong
    Guo, Huimin
    Gao, Qian
    Zou, Xiaoping
    [J]. CANCER LETTERS, 2012, 315 (02) : 198 - 205
  • [25] Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells
    Chengguang Zhao
    Lehe Yang
    Feng Zhou
    Yun Yu
    Xiaojing Du
    Youqun Xiang
    Chenglong Li
    Xiaoying Huang
    Congying Xie
    Zhiguo Liu
    Jiayuh Lin
    Liangxing Wang
    Guang Liang
    Ri Cui
    [J]. Oncogene, 2020, 39 : 3997 - 4013
  • [26] Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer
    Fan, Xuhui
    Fu, Haotian
    Xie, Ni
    Guo, Hangcheng
    Fu, Tiantian
    Shan, Yunfeng
    [J]. AGING-US, 2021, 13 (19): : 22830 - 22842
  • [27] Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
    Zheng, Hailun
    Yang, Lehe
    Kang, Yanting
    Chen, Min
    Lin, Shichong
    Xiang, Youqun
    Li, Caleb
    Dai, Xuanxuan
    Huang, Xiaoying
    Liang, Guang
    Zhao, Chengguang
    [J]. MOLECULAR CARCINOGENESIS, 2019, 58 (04) : 565 - 576
  • [28] Targeting the immune-microenvironment with combined inhibition of MEK and STAT3 in a mouse model of pancreatic cancer
    Roberts, Casey
    VanSaun, Michael N.
    Lamichhane, Purushottam
    Messaggio, Fanuel
    Kovacs, Krisztina
    Srinivasan, Supriya
    Dai, Xizi
    Barretta, Jennifer
    Nagathihalli, Nagaraj
    Merchant, Nipun B.
    [J]. CANCER RESEARCH, 2016, 76
  • [29] Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells
    Zhao, Chengguang
    Yang, Lehe
    Zhou, Feng
    Yu, Yun
    Du, Xiaojing
    Xiang, Youqun
    Li, Chenglong
    Huang, Xiaoying
    Xie, Congying
    Liu, Zhiguo
    Lin, Jiayuh
    Wang, Liangxing
    Liang, Guang
    Cui, Ri
    [J]. ONCOGENE, 2020, 39 (20) : 3997 - 4013
  • [30] STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells
    Fofaria, Neel M.
    Srivastava, Sanjay K.
    [J]. CARCINOGENESIS, 2015, 36 (01) : 142 - 150
12345